AI-generated summary
This short critical review examined studies of intravascular laser irradiation of blood (ILIB) and vascular photobiomodulation (VPBM) for lung diseases, including bronchitis, asthma, pneumonia and tuberculosis. The authors report overall beneficial effects, such as reduced inflammation, improved hemodynamic parameters and gas exchange, and shorter hospital stays, while noting that further studies are needed.
- Who or what was studied
- Patients with lung diseases (bronchitis, asthma, pneumonia, tuberculosis) and animals in experimental studies
- Limits stated in the abstract
- The abstract states the literature lacks randomized, controlled clinical trials, dosimetry is not well understood, and no disadvantages or contraindications were discussed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Photobiomodulation, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.